{"bill":{"bill_id":1671732,"change_hash":"8c5869f6ecb34ac44e477caf59547af1","session_id":2006,"session":{"session_id":2006,"state_id":20,"year_start":2023,"year_end":2023,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"2023 Regular Session"},"url":"https:\/\/legiscan.com\/MD\/bill\/SB202\/2023","state_link":"https:\/\/mgaleg.maryland.gov\/mgawebsite\/Legislation\/Details\/SB0202?ys=2023RS","completed":0,"status":2,"status_date":"2023-02-16","progress":[{"date":"2023-01-20","event":1},{"date":"2023-01-20","event":9},{"date":"2023-02-13","event":10},{"date":"2023-02-16","event":2},{"date":"2023-02-20","event":9}],"state":"MD","state_id":20,"bill_number":"SB202","bill_type":"B","bill_type_id":"1","body":"S","body_id":50,"current_body":"H","current_body_id":49,"title":"Prescription Drug Affordability Board - Upper Payment Limits","description":"Reestablishing the requirement that the Prescription Drug Affordability Board, under certain circumstances, draft a plan of action for implementing a process to set upper payment limits for certain prescription drug products; reestablishing the authority of the Board to set upper payments limits, under certain circumstances, for prescription drug products that are purchased or paid for by or through certain State or local government entities, plans, or programs; etc.","pending_committee_id":1925,"committee":{"committee_id":1925,"chamber":"H","chamber_id":49,"name":"Health and Government Operations"},"referrals":[{"date":"2023-01-20","committee_id":1932,"chamber":"S","chamber_id":50,"name":"Finance"},{"date":"2023-02-20","committee_id":1925,"chamber":"H","chamber_id":49,"name":"Health and Government Operations"}],"history":[{"date":"2023-01-20","action":"First Reading Finance","chamber":"S","chamber_id":50,"importance":1},{"date":"2023-01-21","action":"Hearing 2\/08 at 1:00 p.m.","chamber":"S","chamber_id":50,"importance":0},{"date":"2023-02-13","action":"Favorable Report by Finance","chamber":"S","chamber_id":50,"importance":1},{"date":"2023-02-14","action":"Favorable Adopted","chamber":"S","chamber_id":50,"importance":0},{"date":"2023-02-14","action":"Second Reading Passed","chamber":"S","chamber_id":50,"importance":0},{"date":"2023-02-16","action":"Third Reading Passed (34-11)","chamber":"S","chamber_id":50,"importance":1},{"date":"2023-02-20","action":"Referred Health and Government Operations","chamber":"H","chamber_id":49,"importance":1}],"sponsors":[{"people_id":4575,"person_hash":"cdqocmhl","party_id":"1","state_id":20,"party":"D","role_id":2,"role":"Sen","name":"Brian Feldman","first_name":"Brian","middle_name":"J.","last_name":"Feldman","suffix":"","nickname":"","district":"SD-015","ftm_eid":4909168,"votesmart_id":36097,"opensecrets_id":"","knowwho_pid":213296,"ballotpedia":"Brian_Feldman","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":5,"type":"Crossfiled","sast_bill_number":"HB279","sast_bill_id":1679176}],"subjects":[{"subject_id":22396,"subject_name":"Public Health"},{"subject_id":354090,"subject_name":"Health - Insurance"},{"subject_id":3223,"subject_name":"Committees and Commissions"},{"subject_id":3182,"subject_name":"Drugs"},{"subject_id":20933,"subject_name":"Emergency Bills"},{"subject_id":3277,"subject_name":"Health"},{"subject_id":3243,"subject_name":"Prices"},{"subject_id":3162,"subject_name":"Reports"},{"subject_id":3117,"subject_name":"Rules and Regulations"}],"texts":[{"doc_id":2654675,"date":"2023-01-20","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/MD\/text\/SB202\/id\/2654675","state_link":"https:\/\/mgaleg.maryland.gov\/2023RS\/bills\/sb\/sb0202f.pdf","text_size":108454,"text_hash":"cb9a132105f336243033e0f4d6fd8dc3"},{"doc_id":2697370,"date":"2023-02-14","type":"Engrossed","type_id":4,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/MD\/text\/SB202\/id\/2697370","state_link":"https:\/\/mgaleg.maryland.gov\/2023RS\/bills\/sb\/sb0202t.pdf","text_size":110358,"text_hash":"b1dd33d2f090e73e7b21b7b1bddb5a7d"}],"votes":[{"roll_call_id":1255963,"date":"2023-02-16","desc":"Third Reading Passed","yea":34,"nay":11,"nv":0,"absent":1,"total":46,"passed":1,"chamber":"S","chamber_id":50,"url":"https:\/\/legiscan.com\/MD\/rollcall\/SB202\/id\/1255963","state_link":"https:\/\/mgaleg.maryland.gov\/2023RS\/votes\/Senate\/0114.pdf"}],"amendments":[],"supplements":[{"supplement_id":303685,"date":"0000-00-00","type":"Vote Image","type_id":4,"title":"Vote - Senate - Committee - Finance","description":"Vote Image","mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/MD\/supplement\/SB202\/id\/303685","state_link":"https:\/\/mgaleg.maryland.gov\/2023RS\/votes_comm\/sb0202_fin.pdf","supplement_size":37772,"supplement_hash":"67d3ab5141a5a5f855e579c336e1632f"}],"calendar":[{"type_id":1,"type":"Hearing","date":"2023-02-08","time":"13:00","location":"","description":"Senate Finance Hearing"}]}}